Protocol for a multinational risk-stratified randomised controlled trial in paediatric Crohn’s disease: methotrexate versus azathioprine or adalimumab for maintaining remission in patients at low or high risk for aggressive disease course

Introduction Immunomodulators such as thiopurines (azathioprine (AZA)/6-mercaptopurine (6MP)), methotrexate (MTX) and biologics such as adalimumab (ADA) are well established for maintenance of remission within paediatric Crohn’s disease (CD). It remains unclear, however, which maintenance medication...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Sibylle Koletzko, Richard K Russell, Arie Levine, Dan Turner, Rachel E Harris, Lissy de Ridder, Frank M Ruemmele, Nicholas M Croft, Marina Aloi, Gigi Veereman, Mattias Neyt, Laetitia Bigot
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	BMJ Publishing Group 2020-07-01
Rangatū:	BMJ Open
Urunga tuihono:	https://bmjopen.bmj.com/content/10/7/e034892.full
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!